128 related articles for article (PubMed ID: 16538403)
41. [Changes in the liver].
Nordin A; Renkonen-Sinisalo L; Mäkisalo H
Duodecim; 2001; 117(6):591-3. PubMed ID: 12116492
[No Abstract] [Full Text] [Related]
42. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
43. Outcome following repeat liver resection for colorectal liver metastases.
Nishio H; Hamady ZZ; Malik HZ; Fenwick S; Rajendra Prasad K; Toogood GJ; Lodge JP
Eur J Surg Oncol; 2007 Aug; 33(6):729-34. PubMed ID: 17258883
[TBL] [Abstract][Full Text] [Related]
44. [A clinical study of therapy for local recurrent rectal cancer].
Noda K; Umekita N; Tanaka S; Ohkubo T; Inoue S; Kitamura M
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1830-3. PubMed ID: 17212120
[TBL] [Abstract][Full Text] [Related]
45. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
46. CEA levels and prognosis in colon carcinoma.
Bivins BA; Meeker WR; Griffen WO
J Surg Oncol; 1974; 6(5):413-21. PubMed ID: 4427460
[No Abstract] [Full Text] [Related]
47. Clinicopathologic factors influencing postoperative prognosis in patients with small-sized adenocarcinoma of the lung.
Inoue M; Takakuwa T; Minami M; Shiono H; Utsumi T; Kadota Y; Nasu T; Aozasa K; Okumura M
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):830-6. PubMed ID: 18374763
[TBL] [Abstract][Full Text] [Related]
48. Clinical and pathologic evaluation of patients with recurrence of colorectal cancer five or more years after curative resection.
Cho YB; Chun HK; Yun HR; Lee WS; Yun SH; Lee WY
Dis Colon Rectum; 2007 Aug; 50(8):1204-10. PubMed ID: 17566830
[TBL] [Abstract][Full Text] [Related]
49. Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.
Shariat SF; Park S; Trinh QD; Roehrborn CG; Slawin KM; Karakiewicz PI
J Urol; 2007 Oct; 178(4 Pt 1):1229-36; discussion 1236-7. PubMed ID: 17698116
[TBL] [Abstract][Full Text] [Related]
50. Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis.
Takahashi S; Konishi M; Nakagohri T; Gotohda N; Saito N; Kinoshita T
Jpn J Clin Oncol; 2006 Jun; 36(6):368-75. PubMed ID: 16762969
[TBL] [Abstract][Full Text] [Related]
51. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
[TBL] [Abstract][Full Text] [Related]
53. Influence of preoperative inflammation on outcomes of colorectal cancer surgery.
Fujita T
Ann Surg; 2008 Jun; 247(6):1084-5; author reply 1085-6. PubMed ID: 18520251
[No Abstract] [Full Text] [Related]
54. A critical review of the Glasgow Prognostic Score for colorectal cancer.
Shedda S; Kosmider S; Faragher I; Jones I; Gibbs P
Ann Surg; 2008 Jun; 247(6):1087-8; author reply 1088. PubMed ID: 18520255
[No Abstract] [Full Text] [Related]
55. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
[TBL] [Abstract][Full Text] [Related]
56. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
Li M; Li JY; Zhao AL; Gu J
Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
[TBL] [Abstract][Full Text] [Related]
57. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period.
Ishiguro S; Akasu T; Fujita S; Yamamoto S; Kusters M; Moriya Y
Surgery; 2009 Feb; 145(2):189-95. PubMed ID: 19167974
[TBL] [Abstract][Full Text] [Related]
58. Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
Int J Urol; 2006 Sep; 13(9):1197-201. PubMed ID: 16984552
[TBL] [Abstract][Full Text] [Related]
59. Serum carcinoembryonic antigen level is associated with epidermal growth factor receptor mutations in recurrent lung adenocarcinomas.
Shoji F; Yoshino I; Yano T; Kometani T; Ohba T; Kouso H; Takenaka T; Miura N; Okazaki H; Maehara Y
Cancer; 2007 Dec; 110(12):2793-8. PubMed ID: 17941001
[TBL] [Abstract][Full Text] [Related]
60. [The carcinoembryonic antigen level as an indicator for second look operations].
Halevy A; Adam Y; Eschar J; Zaidman J; Sherf S
Harefuah; 1980 Aug; 99(3-4):59-61. PubMed ID: 7203206
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
